Kimberly Manhard - Jul 25, 2022 Form 4 Insider Report for HERON THERAPEUTICS, INC. /DE/ (HRTX)

Role
EVP, Drug Development, Director
Signature
/s/ Lisa Peraza Attorney-in-fact for Kimberly Manhard
Stock symbol
HRTX
Transactions as of
Jul 25, 2022
Transactions value $
$0
Form type
4
Date filed
7/27/2022, 06:21 PM
Previous filing
Jul 15, 2022
Next filing
Oct 17, 2022

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction HRTX Employee Stock Option (Right to Buy) Award $0 +166K $0.00 166K Jul 25, 2022 Common Stock 166K $3.17 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The stock option vests and becomes exercisable in 8 equal quarterly installments beginning one quarter after the date of grant (07/25/2022).